Portfolio valuations update

MKTUPDTE
Tue, Apr 27 2021 12:01 pm

NZX RELEASE
27 April 2021


Portfolio valuations update

Asset Plus announces that its portfolio revaluation was neutral for the six months to 31 March 2021.

As a result, NTA remains relatively constant at 44.7 cents per share, as valuation gains at 35 Graham Street and Stoddard Road offset the Eastgate revaluation loss.

The total portfolio revaluation gain for the 12 months to 31 March 2021 was $8.9 million, or a 6.5% increase on carrying value.

The portfolio value stands at $172.3 million as at 31 March 2021.

Key points:

• The Eastgate fair value reflects the unconditional sale price less the balance of the Taco Bell development works cost.
• 35 Graham Street increases $2.0 million as a result of compressing capitalisation rates for Auckland office assets, albeit with a short WALE of 0.5 years.
• The Stoddard Road valuation increases $3.0 million, driven by compressing yields for large format and neighbourhood daily needs centres.
• The Munroe Lane “as is valuation” adopts the residual approach and represents costs incurred to date.

While the impact of the Munroe Lane “as if complete valuation” is not reflected, it has increased $4.85 million to $146.85 million, on the back of compressing capitalisation rates for high quality assets.

The independent valuations remain subject to external audit, and will be confirmed in Asset Plus’ audited financial statements for the year ended 31 March 2021, expected to be released on 27 May 2021.

-ENDS-

For further information please contact:

Mark Francis
CEO, Centuria Funds
Management (NZ) Limited, Manager of Asset Plus
09 300 6161

Simon Woollams
Asset Plus CFO, Centuria Funds
Management (NZ) Limited, Manager of Asset Plus
09 300 6161

Stephen Brown-Thomas
Asset Plus Fund Manager, Centuria Funds
Management (NZ) Limited, Manager of Asset Plus
09 300 6161


Announcement PDF


Markets News

Why Steel & Tube is shopping for acquisitions
Markets

Why Steel & Tube is shopping for acquisitions

Steel demand at lows not seen since the 1990s, but Steel & Tube sees opportunities.

Property

Ryman Healthcare taps investors for $1b

The $3.05 per share price is at an almost 30% discount.

Ryman Healthcare taps investors for $1b
Markets

Genesis interested in buying SolarZero

SolarZero's complicated arrangements would have to be sorted.

Genesis interested in buying SolarZero